Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Cancer / September 2006

Tip: Looking for answers? Try searching our database.

Iron chelators have potent and broad antitumor activity

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
ironjustice@aol.com - 28 Sep 2006 14:50 GMT
<<snip>>
Iron chelators can overcome resistance to established chemotherapeutics
<<snip>>

A class of iron chelators with a wide spectrum of potent antitumor
activity that overcomes resistance to chemotherapeutics.
Whitnall M, Howard J, Ponka P, Richardson DR
Proc Natl Acad Sci U S A. 2006 Sep 26;

Novel chemotherapeutics with marked and selective antitumor activity
are essential to develop, particularly those that can overcome
resistance to established therapies. Iron (Fe) is critical for
cell-cycle progression and DNA synthesis and potentially represents a
novel molecular target for the design of new anticancer agents. The aim
of this study was to evaluate the antitumor activity and Fe chelation
efficacy of a new class of Fe chelators using human tumors. In this
investigation, the ligands showed broad antitumor activity and could
overcome resistance to established antitumor agents. The in vivo
efficacy of the most effective chelator identified,
di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone (Dp44mT), was
assessed by using a panel of human xenografts in nude mice. After 7
weeks, net growth of a melanoma xenograft in Dp44mT-treated mice was
only 8% of that in mice treated with vehicle. In addition, no
differences in these latter animals were found in hematological indices
between Dp44mT-treated mice and controls. No marked systemic Fe
depletion was observed comparing Dp44mT- and vehicle-treated mice,
probably because of the very low doses required to induce anticancer
activity. Dp44mT caused up-regulation of the Fe-responsive tumor growth
and metastasis suppressor Ndrg1 in the tumor but not in the liver,
indicating a potential mechanism of selective anticancer activity.
These results indicate that the novel Fe chelators have potent and
broad antitumor activity and can overcome resistance to established
chemotherapeutics because of their unique mechanism of action.

Abstract · PubMed  FullText · SFX · GS  Clip  Export  InterDB ·
Terms  Related · Graph  Cites · Scopus · Tag 10.1073/pnas.0604979103

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com

Man Is A Herbivore!
http://tinyurl.com/a3cc3

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
NICK - 29 Sep 2006 01:08 GMT
> Who loves ya.
> Tom

'Cause your mother quit loving you.

... Tom:  More holes in his head that Swiss Cheese.
ironjustice@aol.com - 29 Sep 2006 03:32 GMT
> > Who loves ya.
> > Tom
>
>  'Cause your mother quit loving you.
>
> ... Tom:  More holes in his head that Swiss Cheese.

>>NICK wrote: Tom:  More holes in his head that Swiss Cheese.<<

"can overcome resistance to established chemotherapeutics"

Do you .. KNOW .. what the above .. concluded .. ?

Dumb it down for .. us .. Nick ..

Don't bother ..

I'll assume you are too stupid to understand .. u-n-d-e-r-s-t-a-n-d ..
the article ..

It says .. AFTER .. all is said and done .. and 'they' have .. "written
you off " .. ie : "resisted established chemotherapeutics " .. and they
have sent you home to .. die .. the use of .. iron .. chelating ..
drugs .. NOW .. when administered .. ?

Heh .. heh ..

"steps in and .. works .. " .. works .. ie: works

Top .. it .. or .. STFU ..

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com

Man Is A Herbivore!
http://tinyurl.com/a3cc3

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.